LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 1,836 pages found matching %3Cscript%3Ealert%28%27What_Security%3F%27%29%3C%2Fscript%3E- Guidant faces Pacemaker Lawsuits: Thousands of Pacemakers could be Defective
Nov-23-06 Indianapolis, IN: According to third quarter reports filed November 9, 2006 by Boston Scientific the company faces around 840 lawsuits related to Guidant pacemakers and defibrillators. Of those cases, 74 are class-action and around 760 are individual suits. The number of suits is up significantly from the 550 lawsuits reported after the company's sec... - Ending FDA's Love Affair With Big Pharma
Nov-22-06 Washington, DC: With the Democrats back in power, critics say officials at the FDA and representatives of Big Pharma had better plan on spending much of their time testifying on Capital Hill in Congressional hearings in 2007. Democrats have spelled out their plans to change how the administration chooses experts to sit on FDA advisory panels and put a... - Kugel Mesh Patches Considered a Serious Recall
Nov-19-06 Murray Hill, NJ: The recall of Kugel Mesh patches that was announced by the FDA earlier this year was serious enough to merit a Class 1 recall. A Class 1 recall means that the recalled device could potentially cause serious injuries, pain, and possibly even death. The recall was announced after Davol Inc, a subsidiary of CR Bard, learned of 31 rin... - Lexapro Legal Problems Mount Against Forest Laboratories
Nov-15-06 Fair Haven, NJ: According to Forest Laboratories' Annual Report, for the year ending March 31, 2006, Celexa and Lexapro , accounted for 68% of the company's sales. The drugs belong to the class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). Sales of Lexapro, the filing notes, increased 16% in the 4th quarter to $464,100... - Unscientific Depression Screenings and Front Groups Boost SSRI Sales
Nov-10-06 USA: Prior to the arrival of the selective serotonin reuptake inhibitor antidepressants (SSRIs) on the market, depression was estimated to affect only 100 people per million. And those 100 people per million sought help from a medical professional trained in psychiatry and the treatment of depression. Since the introduction of SSRIs, rates for dep... - ERISA lawsuit filed against Dell over 401(k)
Nov-10-06 Seattle, WA: A class action lawsuit has been filed against Dell Inc. , on behalf of participants and beneficiaries of the company's 401(k) plan for violating the Employee Retirement Income Security Act (ERISA). The suit, filed September 29 in Seattle, claims that Dell and various defendants breached their fiduciary duties to 401(k) participants. Acc... - Bausch & Lomb Fails to Warn About Dangers of ReNu Contact Lens Solution
Nov-8-06 Greenville, SC: ReNu with MoistureLoc solution has been widely used for the storing, wetting and cleaning of soft contact lenses. But here once again, a drug company has left a product on the market, with no warning to consumers, long after it was aware that serious side effects were developing in people using the product. According to the FDA, cluste... - FDA and Big Pharma Gang Up On Joe Citizen
Nov-6-06 Washington, DC: The botched safety processes at the FDA have had an extremely negative impact on the nation's public health and tens of thousands of people have died as a result of its negligent handling of the Vioxx debacle alone. Americans today can no more trust what's in their medicine cabinets than could the pioneers in the 1800s who filled their m... - Kugel Mesh Patch: Recalled due to Serious Injuries
Nov-3-06 Murray Hill, NJ The US Food and Drug Administration in cooperation with Davol, Inc. have recalled Bard Composix Kugel Mesh Patches following reports of serious injuries related to the patches. The Kugel Mesh Patch is used to repair ventral hernias that are caused by thinning or stretching of scar tissue that forms after surgery. The patch is inserted th... - Many Kaiser Kidney Transplant Patients Still In Limbo
Nov-2-06 San Francisco, CA: In May 2006, following reports by the LA Times and CBS News, Kaiser Permanente closed its 2-year-old San Francisco kidney transplant program amidst allegations that it failed to properly transfer patients on waiting lists, leading to missed opportunities for transplants and patients having to undergo years of unnecessary and grueling... - Green Card Disconnect
Nov-2-06 Spokane, WA " Immigration says my application for citizenship is being held up by the FBI pending a name search but I had an interview 18 months ago and was issued a conditional green card," says Fahd Mohiuebin. "I think the FBI is holding my file because my first name is Arabic." Fahd's wife is a U.S. citizen and a Caucasian, and Fahd is Indian... - Injuries and Death Reported in Patients Implanted with Bard Kugel Mesh Patch
Oct-29-06 Murray Hill, NJ: On January 13, 2006, CR Bard, Inc announced a Class I recall of the Bard Composix Kugel Mesh X-Large Patch after receiving 24 reports that the device's plastic coil ring may not withstand the increased stress associated with certain surgical placement techniques. Davol, Inc, a subsidiary of CR Bard, notified US customers of the recall... - Attorney Predicts Five Thousand Lawsuits Against Guidant
Oct-27-06 Boston, MA: On October 18, 2006, Boston Scientific announced financial earnings for the third quarter 2006, in a press release and reported net sales of $2.026 billion as compared to $1.511 billion for the third quarter of 2005, an increase of 34%. The increase, Boston said, was primarily attributable to the inclusion of $491 million of net sales from... - Oops - Bayer forgot to tell FDA about Lethal Side Effects of Trasylol
Oct-26-06 Washington, DC: On September 29, 2006, the New York Times reported that Bayer "failed to reveal to federal drug officials the results of a large study suggesting that a widely used heart-surgery medicine might increase the risks of death and stroke," citing an FDA announcement. That drug is aprotinin, marketed as Trasylol. Bayer's memory lapse... - Birth Control Patch Lawsuits against J&J Piling Up
Oct-23-06 Princeton, NJ: On October 17, 2006, News Inferno announced that another lawsuit had been filed against Ortho-McNeil, a division of Johnson & Johnson, on behalf of a young Idaho women who was 17 when she was prescribed the Ortho Evra birth control patch , and in less than a month, she developed deep vein thrombosis, a potentially fatal blood clot condition... - No Excuse for marketing Ace Inhibitors to Pregnant Women
Oct-20-06 Waltham, MA In the wake of a study published in June 2006, in The New England Journal of Medicine found a higher rate of birth defects in infants born to mothers who filled prescriptions for Angiotensin-Converting Enzyme Inhibitors (ACE inhibitors), during the first trimester of pregnancy. The FDA advised women to reconsider the use of those drugs b... - Glaxo gets Hit with another Paxil Birth Defects Lawsuit
Oct-17-06 Denver, CO Two years ago, little Eric Jackson was born with persistent pulmonary hypertension, a life-threatening lung disorder in which an infant's arteries to the lungs remain constricted after birth, limiting the amount of blood flow to the lungs and oxygen in the bloodstream. Persistent pulmonary hypertension (PPHN) is associated with substantial in... - Ortho Evra Birth Control Patch - Statistics do not Lie
Oct-13-06 Dallas, TX During one 17-month period between April 2002 and September 2003, the FDA received 9,116 adverse reaction reports on the Ortho Evra birth control patch . In stark contrast, during a 6 year period between 1997 and September 2003, the Ortho birth control pill only generated 1,237 adverse event reports and 6 time more women were using the pill... - Bristol-Myers Slaps Black Box Warning On Coumadin
Oct-11-06 Los Angeles, CA After a request by the FDA, Bristol-Myers Squibb slapped a black box warning on the label of the blood thinning drug Coumadin (generic warfarin), to alert the public about a potentially fatal risk of bleeding . The drug's previous prescribing information noted the risk, but the warning was not highlighted by a black box. Without... - Guidant Settles Three Lawsuits - 549 To Go
Oct-2-06 Corpus Christi, TX Attorneys for the plaintiffs in lawsuits against Guidant and its new owner, Boston Scientific, view the settlement of a Texas case days before a jury trial as a sign that the company is dodging the courtroom. Guidant settled the case for an undisclosed amount with two plaintiffs avoiding a public trial set to begin on September 18, 20...